Drug Discovery

BioPortfolio provides the following four services in respect of research into the development and commercialisation of drugs:

1) BioPortfolio's InDepth service

InDepth is a unique service launched in 2008 by BioPortfolio to provide the professional user with a unique reference resource based on 10,500 medical and research keywords. For each keyword InDepth provides an abstract, latest publications, clinical trials, patents, news and images...more

Cancer / Tumors Carcinomers	Infection / Disease	Pain
Cardiovascular	Inflammation	Immunotherapy

2) BioPortfolio's Management Reports

BioPortfolio stocks over 900 management reports and offers 150 life science management courses...more

3) Bioscience Trend Analysis Biotechnology, Pharmaceutical and Life Science trends

The biointelligence service from BioPortfolio provides data on how the popularity of research areas, techniques, and genes varies over time. Requested metrics on trends can be extracted from the bioinformatics, and patent databases and delivered in formats specified...more

4) DailyUpdates: Tracking breaking research; drug development news & new trials - view Powerpoint Presentation

DailyUpdates was launched in 2002 by the pharmaceutical analysts Lead Discovery to provide the R&D sector with a unique intelligence tool.
LeadDiscovery use proprietary search engine technology to identify breaking journal articles, press releases and clinical trial information of potential interest to the R&D sector. Unlike any other service, selected content is assessed by a panel of industrial experts so that only the information of direct use to the drug development sector is included on DailyUpdates...more

All information is packaged up into 14 therapeutic channels combining ease of use with comprehensive and focused tracking of the drug development sector.

Online Trial: Please select one of the Therapeutic Channels below to view a sample of DailyUpdates online - to request a FREE trial please email peter.barfoot@bioportfolio.com:

In addition LeadDiscobvery have launched DailyUpdatesPlus - view free sample

Are you looking for rapid analysis of breaking R&D activity that will impact on your drug development or marketing activity? If you are UpdatesPlus is for you.

In depth analysis of breaking research: LeadDiscovery already delivers DailyUpdates one of the most popular alert services in the pharmabiotech sector. Based on this proven track record of identifying key R&D activity our industrial panel now offers, through UpdatesPlus, analysis of its importance.

Delivered monthly in an easy to read presentation-ready format: UpdatesPlus has been designed to deliver analysis with clarity characteristic of LeadDiscovery products. Delivered monthly in PowerPoint format, UpdatesPlus is designed to be succinct, easy to read, and simple to convert for the purposes of monthly internal meetings.

Want to find out more? View our free example by clicking the link below

Does this work support a new molecular target? Are we looking at a potential licensing opportunity? Are our competitors advancing their pipeline or has their lead just crashed? These are just some of the questions answered in UpdatesPlus

Information sources: UpdatesPlus focuses on material featured over the previous 4 weeks in DailyUpdates as well as in additional sources. Sources include: Journal articles; Press releases; Clinical Trial databases; Company websites; Proprietary R&D databases; Investor presentations; Key scientific conferences.

Focus: UpdatesPlus is client led. If you have an area that needs to be tracked let us know. UpdatesPlus is suited to covering multiple indications for a single molecular target or multiple molecular targets for a single indication

Cost & Delivery: UpdatesPlus is priced to reflect the size of the area covered. The service can be priced on an exclusive (just your company) or non-exclusive basis. In either case UpdatesPlus is available on a company wide license. Some companies prefer exclusivity since information provided by UpdatesPlus sometimes has the potential to generate a competitive advantage. By way of a guide, UpdatesPlus-Neuronal Nicotinics is priced at $9,500/year. For this, 12 editions will be produced.

Online Trial: Please contact peter.barfoot@bioportfolio.com to request a FREE trial.

5) BioPortfolio's News on Approved Drugs

Launched in 2004 BioPortfolio identified 4,000 approved drugs and customised searches to the BioNews and BioWeb search engines:

Select the latest news for:

See also BioPortfolio's news service to define an RSS feed or subscribe to our proprietary email news alert service.

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.